Our Research & Development Department is constantly working on new projects. ViennaLab is proud of reinvesting 1/3 of its revenue on Product Development - what represents our scientific approach to business. New cancer-related tests are recently being released to the market after having matched the highest CE, ISO 9001 and ISO13485 quality control standards.
The current application fields are Cardiovascular Diseases, Factor V Leiden, PGX-Thrombo for anticoagulant dose requirements, Alzheimer APO-E, Haemochromatosis, Hemoglobinopathies - Thalassemia, Sugar & Lactose Intolerance, FMF, and the newest areas of pharmacogenomics and oncology: KRAS, KRAS-BRAF, BRAF, and PGX-5FU.more »
ViennaLab offers a range of innovative diagnostic tests based on reverse hybridization. The user-friendly StripAssays® up to 48 positions allow the detection of DNA variants including mutations, deletions, methylation status and more. With the StripAssays® proven reliability, the diagnosis of genetic diseases and predispositions can be addressed with highest accuracy.